(BHE) Benchmark Electronics - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US08160H1014
Design, Engineering, Manufacturing, Testing, Integration
Dividends
| Dividend Yield | 1.45% |
| Yield on Cost 5y | 2.94% |
| Yield CAGR 5y | 1.15% |
| Payout Consistency | 98.8% |
| Payout Ratio | 29.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 34.5% |
| Value at Risk 5%th | 50.5% |
| Relative Tail Risk | -11.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -20.04 |
| CAGR/Max DD | 0.59 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.335 |
| Beta | 1.251 |
| Beta Downside | 1.160 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.73% |
| Mean DD | 13.74% |
| Median DD | 12.52% |
Description: BHE Benchmark Electronics November 13, 2025
Benchmark Electronics Inc. (NYSE:BHE) delivers end-to-end product design, engineering, and manufacturing services across the Americas, Asia, and Europe, targeting OEMs in semiconductor capital equipment, industrial, medical, aerospace & defense, and advanced computing & communications.
Its core capabilities span new-product design, prototype testing, custom test and automation equipment, PCB assembly, functional and environmental stress testing, failure analysis, precision machining, electromechanical assembly, and full system integration, complemented by supply-chain management, aftermarket repair, refurbishment, and spare-parts services throughout a product’s lifecycle.
Key recent metrics (FY 2023) include revenue of roughly $1.1 billion, an operating margin of 4.2 %, and a backlog of $750 million, reflecting strong demand from aerospace & defense and semiconductor equipment sectors.
Sector drivers that materially affect BHE’s outlook are the ongoing global semiconductor equipment spend (projected CAGR ≈ 6 % through 2027) and rising U.S. defense budgets, which together underpin growth in high-mix, low-volume manufacturing contracts.
For a deeper quantitative assessment, you may find the ValueRay platform’s detailed financial models useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (37.3m TTM) > 0 and > 6% of Revenue (6% = 156.7m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -7.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.26% (prev 32.32%; Δ -1.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 111.2m > Net Income 37.3m (YES >=105%, WARN >=100%) |
| Net Debt (46.9m) to EBITDA (138.8m) ratio: 0.34 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.2m) change vs 12m ago -1.22% (target <= -2.0% for YES) |
| Gross Margin 10.08% (prev 10.15%; Δ -0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 123.9% (prev 125.2%; Δ -1.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.12 (EBITDA TTM 138.8m / Interest Expense TTM 22.2m) >= 6 (WARN >= 3) |
Altman Z'' 4.42
| (A) 0.39 = (Total Current Assets 1.44b - Total Current Liabilities 618.9m) / Total Assets 2.07b |
| (B) 0.28 = Retained Earnings (Balance) 577.6m / Total Assets 2.07b |
| (C) 0.04 = EBIT TTM 91.7m / Avg Total Assets 2.11b |
| (D) 0.60 = Book Value of Equity 574.0m / Total Liabilities 958.1m |
| Total Rating: 4.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.05
| 1. Piotroski 4.0pt |
| 2. FCF Yield 4.59% |
| 3. FCF Margin 2.87% |
| 4. Debt/Equity 0.30 |
| 5. Debt/Ebitda 0.34 |
| 6. ROIC - WACC (= -4.23)% |
| 7. RoE 3.36% |
| 8. Rev. Trend -35.32% |
| 9. EPS Trend 56.58% |
What is the price of BHE shares?
As of December 07, 2025, the stock is trading at USD 46.96 with a total of 186,701 shares traded.
Over the past week, the price has changed by +4.52%, over one month by +0.56%, over three months by +16.82% and over the past year by -1.32%.
Over the past week, the price has changed by +4.52%, over one month by +0.56%, over three months by +16.82% and over the past year by -1.32%.
Is BHE a buy, sell or hold?
Benchmark Electronics has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BHE.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BHE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.3 | 0.8% |
| Analysts Target Price | 47.3 | 0.8% |
| ValueRay Target Price | 53 | 12.9% |
BHE Fundamental Data Overview November 26, 2025
Market Cap USD = 1.58b (1.58b USD * 1.0 USD.USD)
P/E Trailing = 43.6931
P/S = 0.6068
P/B = 1.3721
P/EG = 1.91
Beta = 1.054
Revenue TTM = 2.61b USD
EBIT TTM = 91.7m USD
EBITDA TTM = 138.8m USD
Long Term Debt = 212.6m USD (from longTermDebt, last quarter)
Short Term Debt = 18.5m USD (from shortTermDebt, last quarter)
Debt = 332.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.63b USD (1.58b + Debt 332.9m - CCE 286.1m)
Interest Coverage Ratio = 4.12 (Ebit TTM 91.7m / Interest Expense TTM 22.2m)
FCF Yield = 4.59% (FCF TTM 74.9m / Enterprise Value 1.63b)
FCF Margin = 2.87% (FCF TTM 74.9m / Revenue TTM 2.61b)
Net Margin = 1.43% (Net Income TTM 37.3m / Revenue TTM 2.61b)
Gross Margin = 10.08% ((Revenue TTM 2.61b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 9.89% (prev 10.08%)
Tobins Q-Ratio = 0.79 (Enterprise Value 1.63b / Total Assets 2.07b)
Interest Expense / Debt = 1.33% (Interest Expense 4.42m / Debt 332.9m)
Taxrate = 30.73% (6.33m / 20.6m)
NOPAT = 63.5m (EBIT 91.7m * (1 - 30.73%))
Current Ratio = 2.32 (Total Current Assets 1.44b / Total Current Liabilities 618.9m)
Debt / Equity = 0.30 (Debt 332.9m / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 0.34 (Net Debt 46.9m / EBITDA 138.8m)
Debt / FCF = 0.63 (Net Debt 46.9m / FCF TTM 74.9m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.80% (Net Income 37.3m / Total Assets 2.07b)
RoE = 3.36% (Net Income TTM 37.3m / Total Stockholder Equity 1.11b)
RoCE = 6.94% (EBIT 91.7m / Capital Employed (Equity 1.11b + L.T.Debt 212.6m))
RoIC = 4.71% (NOPAT 63.5m / Invested Capital 1.35b)
WACC = 8.94% (E(1.58b)/V(1.92b) * Re(10.63%) + D(332.9m)/V(1.92b) * Rd(1.33%) * (1-Tc(0.31)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.31%
[DCF Debug] Terminal Value 59.76% ; FCFE base≈143.0m ; Y1≈93.9m ; Y5≈42.9m
Fair Price DCF = 16.40 (DCF Value 585.3m / Shares Outstanding 35.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 56.58 | EPS CAGR: 7.06% | SUE: 1.89 | # QB: 1
Revenue Correlation: -35.32 | Revenue CAGR: 1.95% | SUE: 1.29 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=-0.038 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.49 | Chg30d=-0.053 | Revisions Net=-1 | Growth EPS=+6.6% | Growth Revenue=+4.9%
P/E Trailing = 43.6931
P/S = 0.6068
P/B = 1.3721
P/EG = 1.91
Beta = 1.054
Revenue TTM = 2.61b USD
EBIT TTM = 91.7m USD
EBITDA TTM = 138.8m USD
Long Term Debt = 212.6m USD (from longTermDebt, last quarter)
Short Term Debt = 18.5m USD (from shortTermDebt, last quarter)
Debt = 332.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.63b USD (1.58b + Debt 332.9m - CCE 286.1m)
Interest Coverage Ratio = 4.12 (Ebit TTM 91.7m / Interest Expense TTM 22.2m)
FCF Yield = 4.59% (FCF TTM 74.9m / Enterprise Value 1.63b)
FCF Margin = 2.87% (FCF TTM 74.9m / Revenue TTM 2.61b)
Net Margin = 1.43% (Net Income TTM 37.3m / Revenue TTM 2.61b)
Gross Margin = 10.08% ((Revenue TTM 2.61b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 9.89% (prev 10.08%)
Tobins Q-Ratio = 0.79 (Enterprise Value 1.63b / Total Assets 2.07b)
Interest Expense / Debt = 1.33% (Interest Expense 4.42m / Debt 332.9m)
Taxrate = 30.73% (6.33m / 20.6m)
NOPAT = 63.5m (EBIT 91.7m * (1 - 30.73%))
Current Ratio = 2.32 (Total Current Assets 1.44b / Total Current Liabilities 618.9m)
Debt / Equity = 0.30 (Debt 332.9m / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 0.34 (Net Debt 46.9m / EBITDA 138.8m)
Debt / FCF = 0.63 (Net Debt 46.9m / FCF TTM 74.9m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.80% (Net Income 37.3m / Total Assets 2.07b)
RoE = 3.36% (Net Income TTM 37.3m / Total Stockholder Equity 1.11b)
RoCE = 6.94% (EBIT 91.7m / Capital Employed (Equity 1.11b + L.T.Debt 212.6m))
RoIC = 4.71% (NOPAT 63.5m / Invested Capital 1.35b)
WACC = 8.94% (E(1.58b)/V(1.92b) * Re(10.63%) + D(332.9m)/V(1.92b) * Rd(1.33%) * (1-Tc(0.31)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.31%
[DCF Debug] Terminal Value 59.76% ; FCFE base≈143.0m ; Y1≈93.9m ; Y5≈42.9m
Fair Price DCF = 16.40 (DCF Value 585.3m / Shares Outstanding 35.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 56.58 | EPS CAGR: 7.06% | SUE: 1.89 | # QB: 1
Revenue Correlation: -35.32 | Revenue CAGR: 1.95% | SUE: 1.29 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=-0.038 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=2.49 | Chg30d=-0.053 | Revisions Net=-1 | Growth EPS=+6.6% | Growth Revenue=+4.9%
Additional Sources for BHE Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle